A noninvasive magnetic neuromodulation therapy significantly improved fecal incontinence symptoms in a sham-controlled Phase 3 trial, with responder rates reaching…
Browsing: Clinical Updates
The medical management of obesity is changing, thanks in part to new views on obesity and widespread adoption of weight-loss…
Guardant Health has received FDA approval for its next-generation liquid biopsy platform, Guardant360 Liquid CDx, expanding the role of blood-based…
Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn’s disease and ulcerative colitis, affects about 1.6 million Americans, many…
Disorders of gut–brain interaction (DGBI), previously referred to as functional gastrointestinal disorders (FGID), have been poorly understood historically. Although providers…
DDW 2026 showcased several studies that may meaningfully influence upper GI clinical practice, particularly in Barrett’s esophagus, EoE, gastroparesis, pancreatitis,…
Picture a statistician in Oslo in 2009, working backward from a mortality assumption to calculate the sample size her trial…
Researchers at the University of Twente have developed a swallowable soft robotic device called SeroTab that could one day reduce…
MASH cirrhosis has traditionally been considered irreversible. However, new data from investigators at Cleveland Clinic, presented at Digestive Disease Week…
An experimental drug called daraxonrasib is generating major excitement in pancreatic cancer after early trials showed it could significantly extend…